VOL. XCIV, NO. 247

★ WIDE MOAT STOCKS COMPARISON ★

NO ADVICE

Wednesday, December 31, 2025

Stock Comparison

Novo Nordisk A/S vs The Procter & Gamble Company

Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.

Novo Nordisk A/S

NOVOB · Nasdaq Copenhagen

Market cap (USD)$232.3B
SectorHealthcare
CountryDK
Data as of2025-12-28
Moat score
85/ 100

Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.

Full stock profile

Dive deeper into Novo Nordisk A/S's moat claims, evidence, and risks.

View NOVOB analysis

The Procter & Gamble Company

PG · New York Stock Exchange

Market cap (USD)$338.4B
SectorConsumer
CountryUS
Data as of2025-12-30
Moat score
79/ 100

Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.

Full stock profile

Dive deeper into The Procter & Gamble Company's moat claims, evidence, and risks.

View PG analysis

Comparison highlights

  • Moat score gap: Novo Nordisk A/S leads (85 / 100 vs 79 / 100 for The Procter & Gamble Company).
  • Segment focus: Novo Nordisk A/S has 3 segments (71.1% in Diabetes care); The Procter & Gamble Company has 5 segments (35.1% in Fabric & Home Care).
  • Moat breadth: Novo Nordisk A/S has 5 moat types across 3 domains; The Procter & Gamble Company has 4 across 2.

Primary market context

Novo Nordisk A/S

Diabetes care

Market

Diabetes pharmaceuticals (GLP-1 for type 2 diabetes, insulin, and related therapies)

Geography

Global

Customer

Payers/providers and patients (via wholesalers/pharmacies/hospitals)

Role

Originator pharma (R&D, regulatory, manufacturing, commercialization)

Revenue share

71.1%

The Procter & Gamble Company

Fabric & Home Care

Market

Branded fabric care and home care (laundry detergents/additives, dish care, surface/home cleaning, air care)

Geography

Global

Customer

Consumers via retail and e-commerce channels

Role

Brand owner / manufacturer

Revenue share

35.1%

Side-by-side metrics

Novo Nordisk A/S
The Procter & Gamble Company
Ticker / Exchange
NOVOB - Nasdaq Copenhagen
PG - New York Stock Exchange
Market cap (USD)
$232.3B
$338.4B
Sector
Healthcare
Consumer
HQ country
DK
US
Primary segment
Diabetes care
Fabric & Home Care
Market structure
Oligopoly
Oligopoly
Market share
33.7% (reported)
35% (reported)
HHI estimate
n/a
n/a
Pricing power
Moderate
Moderate
Moat score
85 / 100
79 / 100
Moat domains
Legal, Supply, Demand
Demand, Supply
Last update
2025-12-28
2025-12-30

Moat coverage

Shared moat types

Brand Trust

Novo Nordisk A/S strengths

IP Choke PointRegulated Standards PipeCapacity MoatLearning Curve Yield

The Procter & Gamble Company strengths

Distribution ControlScale Economies Unit CostInstalled Base Consumables

Segment mix

Novo Nordisk A/S segments

Full profile >

Diabetes care

Oligopoly

71.1%

Obesity care

Duopoly

22.4%

Rare disease

Oligopoly

6.4%

The Procter & Gamble Company segments

Full profile >

Beauty

Oligopoly

17.8%

Grooming

Quasi-Monopoly

7.9%

Health Care

Oligopoly

14.2%

Fabric & Home Care

Oligopoly

35.1%

Baby, Feminine & Family Care

Oligopoly

24%

Want the full wide moat stocks list?

Browse the full ranking of wide moat stocks, updated with moat scores and segment context.

View the moat stocks list

Curation & Accuracy

This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).

Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.